4/A//SEC Filing
Cambrian BioPharma Inc 4/A
Accession 0001567619-23-004608
CIK 0001829802other
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 5:15 PM ET
Size
8.5 KB
Accession
0001567619-23-004608
Insider Transaction Report
Form 4/AAmended
Cambrian BioPharma Inc
10% Owner
Transactions
- Award
Restricted Stock Unit Grant
2022-06-10+4,466→ 5,235,956 total - Award
Stock Option (right to buy)
2022-06-10+14,550→ 14,550 totalExercise: $2.05Exp: 2032-06-09→ Common Stock (14,550 underlying)
Footnotes (4)
- [F1]These shares represent restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of the common stock of the Issuer. The shares underlying the RSUs vest in full on the first anniversary of the date of grant, or June 10, 2023, subject to the James Peyer's continuous service with the Issuer through such vesting date.
- [F2]These shares are held by Cambrian Biopharma, Inc., a Delaware corporation ("Cambrian"). The Chief Executive Officer of Cambrian, James Peyer, may direct the voting and disposition of the shares held by Cambrian, subject in certain instances to the approval of Cambrian's Board of Directors. Mr. Peyer disclaims beneficial ownership of such shares.
- [F3]The shares subject to the option vest and become exercisable in 12 equal monthly installments over a one year period such that the option is fully vested on the first anniversary of the date of grant, or June 10, 2023, subject to the James Peyer's continuous service with the Issuer as of each such vesting date; provided that the option will in any case be fully vested on the date of the Company's next annual stockholder meeting, subject to the James Peyer's continuous service with the Issuer through such vesting date.
- [F4]Amendment filed solely to correct the number of shares owned.
Documents
Issuer
Sensei Biotherapeutics, Inc.
CIK 0001829802
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001797409
Filing Metadata
- Form type
- 4/A
- Filed
- Mar 6, 7:00 PM ET
- Accepted
- Mar 7, 5:15 PM ET
- Size
- 8.5 KB